Shares of CARGO Therapeutics , Inc. (NASDAQ:CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 ...
Shares in clinical-stage biotechnology company Cargo Therapeutics (CRGX) have plunged after it scrapped trials of a cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback